Bio Spectator

Bridgebio launches phase 1/2 of ‘4th generation EGFR TKI drug’ for lung cancer

Neo-Imuntech, solid cancer’NT-I7+Kitruda’ combined use “Phase 2 started”

NovaVax,’Corona 19 Vaccine’ final “prevention efficiency 96.4%”

[BioS 레터]’AI role’ throughout the entire process of new drug development

Toolgen, Genexine & GenenBio and’Xenograft’ business agreement-BioSpectator

GI Innovation passed the KOSDAQ listing’A, A, A’

[BioS 레터]Intestinal-closing,’Corona 19′ and microbiome-Biospectator

[BioS 레터]Intestinal-closing,’Corona 19′ and microbiome-Biospectator

[BioS 레터]Intestinal-closing,’Corona 19′ and microbiome-Biospectator

Regeneron, “Corona 19 Antibody” Prevention Phase 3 “No Symptoms”

Central Pharmaceutical Latitude Celltrion Corona 19 Antibody

Ministry of Food and Drug Safety Advisory Group, Celltrion Corona 19 Antibody “Conditional Permission Recommendation”